Invacare Cost of Goods Sold 2010-2023 | IVCRQ

Invacare cost of goods sold from 2010 to 2023. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Invacare Annual Cost of Goods Sold
(Millions of US $)
2022 $566
2021 $633
2020 $605
2019 $666
2018 $705
2017 $697
2016 $764
2015 $830
2014 $923
2013 $967
2012 $989
2011 $1,009
2010 $952
2009 $1,200
Invacare Quarterly Cost of Goods Sold
(Millions of US $)
2023-03-31 $122
2022-12-31 $133
2022-09-30 $139
2022-06-30 $141
2022-03-31 $153
2021-12-31 $163
2021-09-30 $164
2021-06-30 $165
2021-03-31 $142
2020-12-31 $158
2020-09-30 $152
2020-06-30 $140
2020-03-31 $155
2019-12-31 $165
2019-09-30 $168
2019-06-30 $171
2019-03-31 $162
2018-12-31 $176
2018-09-30 $179
2018-06-30 $179
2018-03-31 $171
2017-12-31 $182
2017-09-30 $180
2017-06-30 $168
2017-03-31 $167
2016-12-31 $178
2016-09-30 $195
2016-06-30 $201
2016-03-31 $190
2015-12-31 $202
2015-09-30 $206
2015-06-30 $209
2015-03-31 $212
2014-12-31 $230
2014-09-30 $236
2014-06-30 $235
2014-03-31 $222
2013-12-31 $236
2013-09-30 $242
2013-06-30 $251
2013-03-31 $238
2012-12-31 $235
2012-09-30 $252
2012-06-30 $257
2012-03-31 $245
2011-12-31 $46
2011-09-30 $325
2011-06-30 $331
2011-03-31 $305
2010-12-31 $57
2010-09-30 $306
2010-06-30 $304
2010-03-31 $285
2009-12-31 $313
2009-09-30 $303
2009-06-30 $294
2009-03-31 $290
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47